Fexofenadine hydrochloride in the treatment of allergic disease: a review

Fexofenadine hydrochloride in the treatment of allergic disease: a review

David Axelrod1, Leonard Bielory2Division of Allergy, Immunology and Rheumatology, UMDNJ-New Jersey Medical School, 1Department of Medicine, 2Departments of Medicine, Pediatrics, Ophthalmology and Visual Sciences, Newark, New Jersey, USAAbstract: Fexofenadine is a selective, non-sedating H1 receptor...

Full description

Bibliographic Details
Main Authors:	David Axelrod, Leonard Bielory
Format:	Article
Language:	English
Published:	Dove Medical Press 2008-09-01
Series:	Journal of Asthma and Allergy
Online Access:	http://www.dovepress.com/fexofenadine-hydrochloride-in-the-treatment-of-allergic-disease-a-revi-a2250

Similar Items

A Randomized Control Trail of Stepwise Treatment with Fluticasone Propionate Nasal Spray and Fexofenadine Hydrochloride Tablet for Seasonal Allergic Rhinitis
by: Goro Takahashi, et al.
Published: (2012-01-01)

Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation
by: Sultan AA, et al.
Published: (2022-08-01)

Correction: Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis
by: Eli O. Meltzer, et al.
Published: (2022-12-01)

Solid Form and Phase Transformation Properties of Fexofenadine Hydrochloride during Wet Granulation Process
by: Suye Li, et al.
Published: (2021-05-01)

Improved Dissolution Rate and Intestinal Absorption of Fexofenadine Hydrochloride by the Preparation of Solid Dispersions: In Vitro and In Situ Evaluation
by: Basanth Babu Eedara, et al.
Published: (2021-02-01)

Application of green first derivative synchronous spectrofluorometric method for quantitative analysis of fexofenadine hydrochloride and pseudoephedrine hydrochloride in pharmaceutical preparation and spiked human plasma
by: Sherif Ramzy, et al.
Published: (2022-08-01)

Comparison of the efficacy of combined budesonide and fexofenadine versus combined fluticasone propionate and fexofenadine on the expression of class-4 semaphorins and their receptors in the peripheral blood cells of patients with allergic rhinitis
by: Gelayol Asadi, et al.
Published: (2024-01-01)

The effect of treatment with fexofenadine and fluticasone propionate on the gene expression levels of Th9 transcription factors in patients with allergic rhinitis
by: Ali asghar Askari, et al.
Published: (2021-12-01)

Altered Expression of Long Non-Coding RNAs NEAT1, H19, and MALAT1 in Peripheral Blood ‎Cells of Patients with Allergic Rhinitis after Treatment with Pharmaceutical Combinations of ‎ Budesonide and Fexofenadine versus Fluticasone Propionate and Fexofenadine
by: Gelayol Asadi, et al.
Published: (2023-03-01)

Update meta-analysis on the efficacy and safety issues of fexofenadine
by: René Maximiliano Gómez, MD, PhD, et al.
Published: (2023-07-01)

Comparative efficacy of fexofenadine and levocetirizine in chronic idiopathic urticaria
by: Godse K, et al.
Published: (2007-01-01)

HPLC methods of fexofenadine quantitative analysis in rabbits’ liver
by: P. Yu. Mylnikov, et al.
Published: (2020-05-01)

Topical olopatadine hydrochloride versus ketotifen fumarate for allergic conjunctivitis
by: Dharmistha Patel, et al.
Published: (2018-01-01)

Interaction between Fexofenadine and CYP Phenotyping Probe Drugs in Geneva Cocktail
by: Marija Bosilkovska, et al.
Published: (2019-10-01)

Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice
by: Xiangli Zhao, et al.
Published: (2021-10-01)

Increasing the knowledge base of ocular allergy epidemiology
by: Leonard Bielory
Published: (2013-07-01)

Olopatadine Hydrochloride and Fluticasone Propionate in Topical Treatment of Allergic Rhinitis: A Single Blind Randomised Study
by: Abhay Havle, et al.
Published: (2016-12-01)

Effect of <i>Rumex Acetosa</i> Extract, a Herbal Drug, on the Absorption of Fexofenadine
by: Jung Hwan Ahn, et al.
Published: (2020-06-01)

Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease
by: Jae-Bong Kim, et al.
Published: (2024-02-01)

Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye
by: Lin Lin, et al.
Published: (2024-05-01)

False Positive Tramadol Urine Testing in Patients Taking Fexofenadine: A Tale of Two Consecutive Cases
by: Suhair Mohammed Yousuf, et al.
Published: (2023-01-01)

Evaluation of Efficacy of Nasal Sprays Containing Mometasone Furoate and Azelastine Hydrochloride in the Management of Allergic Rhinitis
by: Kemal Görür, et al.
Published: (2002-03-01)

Novel Nanotherapeutics for Cancer Immunotherapy by PD-L1-Aptamer-Functionalized and Fexofenadine-Loaded Albumin Nanoparticles
by: Xialian Lai, et al.
Published: (2023-03-01)

Efficacy of Naproxen/Fexofenadine (SJP-003) in the Prevention of Side Effects of Influenza Vaccination: Four Case Studies
by: Pantea Kiani, et al.
Published: (2022-09-01)

Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia – An Observational Real-World Clinical Study
by: Fifer S, et al.
Published: (2023-01-01)

Quality by Design for the Development and Analysis of Enhanced In-Situ Forming Vesicles for the Improvement of the Bioavailability of Fexofenadine HCl In Vitro and In Vivo
by: Ali M. Nasr, et al.
Published: (2020-04-01)

Facile electrostatic incorporation of the food dye, Dianthine B, for an ultrasensitive tracking and quantification of fexofenadine drug employing an ''on-on++ fluorescence'' strategy
by: Ahmed Abdulhafez Hamad, et al.
Published: (2023-08-01)

Nanotechnology for the Treatment of Allergic Conjunctival Diseases
by: Yu-Chi Liu, et al.
Published: (2020-10-01)

Nanotechnology for the treatment of allergic conjunctival diseases
by: Liu, Yu-Chi, et al.
Published: (2021)

The place of Omalizumab in the treatment of allergic diseases
by: O. M. Kurbacheva, et al.
Published: (2019-12-01)

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis
by: Jean Bousquet, et al.
Published: (2023-10-01)

Pharmacokinetics of tacrine hydrochloride in Alzheimer's disease.
by: Forsyth, DR, et al.
Published: (1989)

The Efficacy of the Combination of Naproxen and Fexofenadine (SJP-003) to Prevent or Reduce Side Effects of Receiving Multiple Travel Vaccines: A Case Report
by: Pantea Kiani, et al.
Published: (2022-07-01)

A Review on Maternal and Infant Microbiota and Their Implications for the Prevention and Treatment of Allergic Diseases
by: Yifan Wu, et al.
Published: (2023-05-01)

Cetirizine for the treatment of allergic diseases in children: A systematic review and meta-analysis
by: Pengxiang Zhou, et al.
Published: (2022-08-01)

Naftifine hydrochloride (NH) in the treatment of pityriasis versicolor
by: L. P. Kotrekhova, et al.
Published: (2017-08-01)

THE USE OF NAFTIFINI HYDROCHLORIDE AND ITS ADVANTAGES IN THE TREATMENT OF VARIOUS TYPERS OF FUNGAL DISEASES
by: S. I. Kosenkova, et al.
Published: (2019-01-01)

Fabrication and Applications of Potentiometric Membrane Sensors Based on γ-Cyclodextrin and Calixarene as Ionophores for the Determination of a Histamine H1-Receptor Antagonist: Fexofenadine
by: Haitham Alrabiah, et al.
Published: (2023-06-01)

Meloxicam hydrochloride
by: Fermin Flores Manuel, et al.
Published: (2023-03-01)

Mepacrine hydrochloride
by: 982 SIRIM